Abnormalities of the p53 tumour suppressor gene in mature B-cell neoplasms

Hematology

Volumn 6, Issue 4, 2001, Pages 241-254

  Gruszka Westwood, Alicja M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Mature B cell lymphoproliferative disorders; p53

Indexed keywords

PHOSPHOPROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

ADVANCED CANCER; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER STAGING; CANCER THERAPY; CARCINOGENESIS; CHROMOSOME 17P; CODON; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; FOLLICULAR LYMPHOMA; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; MUTATIONAL ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0035719877     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245332.2001.11746577     Document Type: Article

References (74)

1. "p53 and human cancer: The first ten thousand mutations"
2. "Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study"
3. "Exploiting the p53 pathway for cancer diagnosis and therapy"
4. "Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma"
5. "Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma"
6. "Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization"
7. "Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas"
8. "Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas"
9. "Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas"
10. "Disrupted p53 function as predictor of treatment failure and poor prognosis in B and T-cell non-Hodgkin's lymphoma"
11. "p53 gene mutations and rearrangements in non-Hodgkin's lymphoma"
12. "Screening patients for heterozygous p53 mutations using a functional assay in yeast"
13. "Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction"
14. "p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations"
15. "p53 abnormalities in B-cell prolymphocytic leukemia"
16. "Detection of p53 mutations in hematological malignancies: Comparison between immunocytochemistry and DNA analysis"
17. "Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators"
18. "Significance of p53 mutations in patients with chronic lymphocytic leukemia: A sequential study of 30 patients"
19. "Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: A report on 39 cases with cytogenetic analysis"
20. "p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias"
21. "p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis"
22. "p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia"
23. "p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis"
24. "Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: Frequent occurrence of dicentric rearrangements and possible association with adverse outcome"
25. "Genomic aberrations and survival in chronic lymphocytic leukemia"
26. "p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis"
27. "p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas"
28. "Large-cell variants of mantle cell lymphoma: Cytologic characteristics and p53 anomalies may predict poor outcome"
29. "Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants"
30. "p53 over-expression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)"
31. "Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features"
32. "Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1 Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma"
33. "Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma"
34. "p53 mutation is associated with progression in follicular lymphomas"
35. "p53 mutations are associated with histologic transformation of follicular lymphoma"
36. "Mutations of p53 gene and their relation to disease progression in B-cell lymphoma"
37. "Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes"
38. "The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma"
39. "p53 in lymphomas of mucosal-associated lymphoid tissues"
40. "Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue"
41. "Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas"
42. "Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin"
43. "Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations"
44. "p53 abnormalities in splenic lymphoma with villous lymphocytes"
45. "Analysis of the P53 RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase fluorescence in situ hybridization study"
46. "Molecular cytogenetic characterization of marginal zone B-cell lymphoma: Correlation with clinico-pathologic findings in 14 cases"
47. "Splenic marginal zone lymphoma with increased number of blasts: An aggressive variant?"
48. "p53 gene mutations in multiple myeloma"
49. "Rare occurrence of P53 gene mutations in multiple myeloma"
50. "p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy"
51. "p53 and RAS gene mutations in multiple myeloma"
52. "Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy"
53. "Analysis of p73 and p53 gene deletions in multiple myeloma"
54. "Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: Correlation with cyclin-D1 immunoreactivity"
55. "p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant"
56. "p53 mutations in hairy cell leukemia"
57. "Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma"
58. "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma"
59. "Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study"
60. "Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas"
61. "Aberrations of the p53 pathway components p53 MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma"
62. "The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors"
63. "Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: A report of 48 cases"
64. "Clinical significance of detecting p53 protein in Burkitt lymphoma and B-cell acute lymphoblastic leukemia using immunocytochemistry"
65. "Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma"
66. "A comprehensive system to explore p53 mutations"
67. "An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD)"
68. "A rapid fluorescence based multiplex polymerase chain reaction-single-strand conformation polymorphism method for p53 mutation detection"
69. "Detection of mutation of the p53 gene with high sensitivity by fluorescence-based PCR-SSCP analysis using low-pH buffer and an automated DNA sequencer in a large number of DNA samples"
70. "A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning"
71. "Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations"
72. "Fluorescence-based single-strand conformation polymorphism analysis of mutations by capillary electrophoresis"
73. "Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary- and microchip-based electrophoresis"
74. "High dose methyl prednisolone (HDMP), alone or in combination with other drugs guided by the DISC Assay, as salvage treatment for CLL with p53 abnormalities"